JAMA Network
JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
2025-05-05
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
- Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
Comments (3)
More Episodes
All Episodes>>You may also like
Get this podcast on your phone, Free
Create Your Podcast In Minutes
- Full-featured podcast site
- Unlimited storage and bandwidth
- Comprehensive podcast stats
- Distribute to Apple Podcasts, Spotify, and more
- Make money with your podcast
It is Free
